Abstract
Clinical outcomes reported after treatment of infrapopliteal lesions with drug-eluting stents (DESs) have been more favorable compared with percutaneous transluminal angioplasty with a bailout bare metal stent (PTA-BMS) through midterm followup in patients with critical limb ischemia. In the present
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have